Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population
Reimbursement for obesity-focused GLP-1 therapies remains inconsistent, particularly for oral formulations indicated for obesity management
Key Takeaways GLP-1 medications lower your appetite, quiet "food noise," and slow digestion, so you feel full longer
You forget the shaker
Clinical Evidence for Fluid Balance Improvement Randomized controlled trials of semaglutide (SUSTAIN-6, SUSTAIN-7) and tirzepatide (SURMOUNT-1, SURMOUNT-2) demonstrate modest reductions in peripheral edema and self-reported bloating alongside weight loss
US$ 26.27
US$ 27.99
US$ 29.07
.png)
